Discover
IOBT
IO Biotech, Inc.
0.05
1 x 0.04
6 x 0.04
bid
ask
+
0.00
0.00%
4 @ 04:00 PM
0.05 +0.01 (13.75%)
| Ytd | -92.12% | |
| 1y | -97.00% |
0.03
day range
0.06
0.66
52 week range
2.10
| Open | 0.03 | Prev Close | 0.05 | Low | 0.03 | High | 0.06 | Mkt Cap | 58.61M |
| Vol | 469.19M | Avg Vol | 347.79K | EPS | -1.29 | P/E | N/A | Forward P/E | -0.76 |
| Beta | 0.42 | Short Ratio | 1.89 | Inst. Own | 76.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 0.99 | 200-d Avg | 1.26 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 19.36M | ||
| Research and Development Expense | 13.74M | ||
| Selling, General and Administrative Expense | 5.61M | ||
| Operating Income | -19.35M | ||
| Interest Expense | 886.00K | ||
| Income Tax Expense | -1.66M | ||
| Net Income | -8.38M | ||
| Net Income Common Stock | -8.38M | ||
| Net Income Common Stock (USD) | -8.38M | ||
| Consolidated Income | -8.38M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -9.16M | ||
| Earning Before Interest & Taxes (USD) | -9.16M | ||
| Weighted Average Shares | 66.94M | ||
| Weighted Average Shares Diluted | 66.94M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.66M | ||
| Cash and Equivalents (USD) | 30.66M | ||
| Investments | 268.00K | ||
| Investments Non-Current | 268.00K | ||
| Current Assets | 36.83M | ||
| Property, Plant & Equipment Net | 1.85M | ||
| Total Assets | 39.96M | ||
| Debt Current | 788.00K | ||
| Total Debt | 18.12M | ||
| Current Liabilities | 18.31M | ||
| Debt Non-Current | 17.33M | ||
| Total Liabilities | 39.05M | ||
| Accumulated Retained Earnings (Deficit) | -416.33M | ||
| Accumulated Other Comprehensive Income | -7.16M | ||
| Shareholders Equity | 911.00K | ||
| Shareholders Equity (USD) | 911.00K | ||
| Assets Non-Current | 3.13M | ||
| Total Debt (USD) | 18.12M | ||
| Liabilities Non-Current | 20.73M | ||
| Trade and Non-Trade Payables | 5.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 230.00K | ||
| Net Cash Flow from Financing | 21.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.79M | ||
| Capital Expenditure | -4.00K | ||
| Issuance (Purchase) of Equity Shares | 6.57M | ||
| Issuance (Repayment) of Debt Securities | 14.70M | ||
| Net Cash Flow from Investing | -4.00K | ||
| Net Cash Flow from Operations | -18.48M | ||
| Effect of Exchange Rate Changes on Cash | -255.00K | ||
| Share Based Compensation | 1.48M | ||